NovaBay Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
NovaBay Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • NovaBay Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.06M, a 52% decline year-over-year.
  • NovaBay Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$9.05M, a 27.7% increase year-over-year.
  • NovaBay Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$7.6M, a 47.3% increase from 2022.
  • NovaBay Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$14.4M, a 62.7% decline from 2021.
  • NovaBay Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$8.86M, a 37.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$9.05M -$1.06M -$363K -52% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$8.69M -$1.05M -$2K -0.19% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$8.69M -$2.44M -$1.09M -81.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$7.6M -$4.5M +$4.92M +52.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$12.5M -$698K -$241K -52.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$12.3M -$1.05M +$1.1M +51.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$13.4M -$1.35M +$1.04M +43.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$14.4M -$9.43M -$6.23M -195% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$8.19M -$457K +$1.83M +80% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$10M -$2.15M -$293K -15.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$9.72M -$2.38M -$862K -56.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$8.86M -$3.19M -$1.44M -81.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$7.43M -$2.29M -$227K -11% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$7.2M -$1.86M -$788K -73.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$6.41M -$1.52M +$15K +0.98% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$6.43M -$1.76M +$480K +21.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$6.91M -$2.06M -$350K -20.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$6.56M -$1.07M +$308K +22.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$6.86M -$1.54M +$2.54M +62.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$9.4M -$2.24M -$627K -38.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-29
Q3 2019 -$8.77M -$1.71M +$97K +5.36% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$8.87M -$1.38M +$704K +33.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$9.57M -$4.07M -$1.7M -71.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$7.87M -$1.61M -$2M -511% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-25
Q3 2018 -$5.87M -$1.81M +$360K +16.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$6.23M -$2.08M -$326K -18.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$5.9M -$2.37M +$1.41M +37.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$7.31M $392K +$2.42M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-26
Q3 2017 -$9.73M -$2.17M -$108K -5.24% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$9.63M -$1.76M +$483K +21.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$10.1M -$3.78M +$874K +18.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$11M -$2.03M +$4.24M +67.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-29
Q3 2016 -$15.2M -$2.06M +$3.29M +61.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$18.5M -$2.24M +$2.62M +53.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$21.1M -$4.65M +$10K +0.22% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$21.1M -$6.27M -$1.34M -27.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-21
Q3 2015 -$19.8M -$5.35M -$1.24M -30% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$18.6M -$4.86M -$1.07M -28.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$17.5M -$4.66M -$583K -14.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$16.9M -$4.93M -$60K -1.23% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-23
Q3 2014 -$16.8M -$4.11M -$1.13M -37.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$15.7M -$3.79M +$364K +8.77% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$16.1M -$4.08M -$591K -16.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$15.5M -$4.87M -$2.02M -71.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-04
Q3 2013 -$13.5M -$2.98M -$2.88M -2713% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$10.6M -$4.15M -$1.28M -44.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 -$9.31M -$3.49M -$1M -40.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 -$8.31M -$2.84M -$375K -15.2% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-26
Q3 2012 -$7.93M -$106K +$242K +69.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$8.18M -$2.88M -$3.32M -753% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 -$4.86M -$2.49M -$540K -27.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q4 2011 -$4.32M -$2.47M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-06
Q3 2011 -$348K +$1.3M +78.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 $440K +$1.63M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$1.95M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
Q3 2010 -$1.65M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$1.19M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.